Main Article Content
Abstract
RÉSUMÉ
L’ostéonécrose aseptique (ONA) de la tête fémorale est une pathologie caractérisée par une nécrose osseuse épiphysaire secondaire à des mécanismes ischémiques et/ou cytotoxiques, affectant souvent l’adulte jeune et entrainant des douleurs de la hanche et une altération de la qualité de vie. Il s’agit d’une complication rare d’une corticothérapie de longue durée et à forte dose. La survenue d’une ONA de la tête fémorale secondaire à une application de longue durée des dermocorticoïdes est très rare. L’implication du diabète sucré dans l’augmentation du risque d’ONA a été récemment rapportée.
Dans cet article, nous rapportons un cas rare d’une patiente de 67ans suivie pour un diabète sucré de type 2 déséquilibré, ayant présentée une ONA bilatérale de la tête fémorale après une application chronique de dermocorticoïdes pour une dépigmentation cosmétique volontaire.
ABSTRACT
Avascular necrosis (AVN) of the femoral head is a condition characterized by an ischemic or cytotoxic necrosis of epiphyseal bone, frequently affecting young adults and responsible for hip pain and impaired quality of life. This is a rare complication of long-term corticosteroid treatment therapy with high doses. Avascular necrosis (AVN) developed after long-term topical corticosteroid application is very rare. Diabetes mellitus has been reported to increase risk of AVN. In this article, we report a rare case of a 67-year-old female patient with poorly controlled type 2 diabetes mellitus, who developed bilateral femoral head avascular necrosis following long-term application of topical corticosteroid for voluntary cosmetic depigmentation.
Keywords
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
- Kamal D, Trăistaru R, Alexandru DO, Kamal CK, Pirici D, Pop OT, Mălăescu DG. Morphometric findings in avascular necrosis of the femoral head. Rom J Morphol Embryol. 2012 ;53(3) :763-7.
- Teimouri M, Motififard M, Hatami S. Etiology of Femoral Head Avascular Necrosis in Patients : A Cross-Sectional Study. Adv Biomed Res. 2022 ;11 :115.
- Zalavras CG, Lieberman JR. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg. 2014 ; 22(7) :455-64.
- Dharmshaktu P, Aggarwal A, Dutta D, Kulshreshtha B. Bilateral femoral head avascular necrosis with a very low dose of oral corticosteroid used for panhypopituitarism. BMJ Case Rep. 2016 ;2016 : 1-3.
- KOUOTOU E A. Histoire de la Dépigmentation Volontaire. Health Sci. Dis. 2019. 20 (6) : 1-5
- Kourouma S, Gbery IP, Kaloga M, Ecra EJ, Sangaré A, Kouassi IY, Kassi K, Kouassi AK, Yoboué PY. Dépigmentation cutanée cosmétique des femmes noires : résultats d’une enquête CAP à Abidjan (Côte d’Ivoire). Pan Afr Med J. 2016 ;24 :159.
- Konarski W, Poboży T, Kotela A, Śliwczyński A, Kotela I, Hordowicz M, Krakowiak J. Does Diabetes Mellitus Increase the Risk of Avascular Osteonecrosis? A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022 ;19(22) :15219.
- Guerado E, Caso E. The physiopathology of avascular necrosis of the femoral head: an update. Injury. 2016 47 (6) : S16-S26.
- Assouline-Dayan Y, Chang C, Greenspan A, et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002 ;32 :94–124.
- Aaron RK, Voisinet A. Corticosteroid associated avascular necrosis: dose relationship and early diagnosis. Ann NY Acad Sci 2011 ;1240 :38–46.
- Kubo T, Kojima A, Yamazoe S, Ueshima K, Yamamoto T, Hirasawa Y. Osteonecrosis of the femoral head that developed after long-term topical steroid application. J Orthop Sci. 2001 ;6(1) :92-4.
- Mahé A. The practice of skin-bleaching for a cosmetic purpose in immigrant communities: cosmetic skin-bleaching. J Travel Med. 2014 ;21(4) :282–7.
- Kisielinski K, Niedhart C, Schneider U, Niethard FU. Osteonecrosis 15 years after femoral neck fracture and long-term low-dose inhaled corticosteroid therapy. Joint Bone Spine. 2004 ; 71(3) :237-9
- Karkoulias K, Charokopos N, Kaparianos A, Sampsonas F, Tsiamita M, Spiropoulos K. Aseptic femoral head necrosis in a patient receiving long term courses of inhaled and intranasal corticosteroids. Tuberk Toraks. 2007 ; 55(2) :182-5.
- Demir S, Nawroth PP, Herzig S, Ekim Üstünel B. Emerging Targets in Type 2 Diabetes and Diabetic Complications. Adv Sci (Weinh). 2021 ;8(18) : e2100275.
- Pijnenburg L, Felten R, Javier RM. Ostéonécroses aseptiques, une revue générale des ostéonécroses de la hanche, et au-delà [A review of avascular necrosis, of the hip and beyond]. Rev Med Interne. 2020 ;41(1):27-36.
References
Kamal D, Trăistaru R, Alexandru DO, Kamal CK, Pirici D, Pop OT, Mălăescu DG. Morphometric findings in avascular necrosis of the femoral head. Rom J Morphol Embryol. 2012 ;53(3) :763-7.
Teimouri M, Motififard M, Hatami S. Etiology of Femoral Head Avascular Necrosis in Patients : A Cross-Sectional Study. Adv Biomed Res. 2022 ;11 :115.
Zalavras CG, Lieberman JR. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg. 2014 ; 22(7) :455-64.
Dharmshaktu P, Aggarwal A, Dutta D, Kulshreshtha B. Bilateral femoral head avascular necrosis with a very low dose of oral corticosteroid used for panhypopituitarism. BMJ Case Rep. 2016 ;2016 : 1-3.
KOUOTOU E A. Histoire de la Dépigmentation Volontaire. Health Sci. Dis. 2019. 20 (6) : 1-5
Kourouma S, Gbery IP, Kaloga M, Ecra EJ, Sangaré A, Kouassi IY, Kassi K, Kouassi AK, Yoboué PY. Dépigmentation cutanée cosmétique des femmes noires : résultats d’une enquête CAP à Abidjan (Côte d’Ivoire). Pan Afr Med J. 2016 ;24 :159.
Konarski W, Poboży T, Kotela A, Śliwczyński A, Kotela I, Hordowicz M, Krakowiak J. Does Diabetes Mellitus Increase the Risk of Avascular Osteonecrosis? A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022 ;19(22) :15219.
Guerado E, Caso E. The physiopathology of avascular necrosis of the femoral head: an update. Injury. 2016 47 (6) : S16-S26.
Assouline-Dayan Y, Chang C, Greenspan A, et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002 ;32 :94–124.
Aaron RK, Voisinet A. Corticosteroid associated avascular necrosis: dose relationship and early diagnosis. Ann NY Acad Sci 2011 ;1240 :38–46.
Kubo T, Kojima A, Yamazoe S, Ueshima K, Yamamoto T, Hirasawa Y. Osteonecrosis of the femoral head that developed after long-term topical steroid application. J Orthop Sci. 2001 ;6(1) :92-4.
Mahé A. The practice of skin-bleaching for a cosmetic purpose in immigrant communities: cosmetic skin-bleaching. J Travel Med. 2014 ;21(4) :282–7.
Kisielinski K, Niedhart C, Schneider U, Niethard FU. Osteonecrosis 15 years after femoral neck fracture and long-term low-dose inhaled corticosteroid therapy. Joint Bone Spine. 2004 ; 71(3) :237-9
Karkoulias K, Charokopos N, Kaparianos A, Sampsonas F, Tsiamita M, Spiropoulos K. Aseptic femoral head necrosis in a patient receiving long term courses of inhaled and intranasal corticosteroids. Tuberk Toraks. 2007 ; 55(2) :182-5.
Demir S, Nawroth PP, Herzig S, Ekim Üstünel B. Emerging Targets in Type 2 Diabetes and Diabetic Complications. Adv Sci (Weinh). 2021 ;8(18) : e2100275.
Pijnenburg L, Felten R, Javier RM. Ostéonécroses aseptiques, une revue générale des ostéonécroses de la hanche, et au-delà [A review of avascular necrosis, of the hip and beyond]. Rev Med Interne. 2020 ;41(1):27-36.